Ísrael - enska - Ministry of Health

merck sharp & dohme israel ltd - ganirelix 0.25 mg / 0.5 ml - solution for injection - the prevention of premature luteinsing hormone (lt) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

Singapúr - enska - HSA (Health Sciences Authority)

merck pte. ltd. - cetrorelix (as cetrorelix acetate) - injection - 0.25 mg - cetrorelix (as cetrorelix acetate) 0.25 mg

Kanada - enska - Health Canada

organon canada inc. - ganirelix (ganirelix acetate) - solution - 250mcg - ganirelix (ganirelix acetate) 250mcg - gonadotropin-releasing hormone antagonists

Kanada - enska - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 0.25mg - cetrorelix (cetrorelix acetate) 0.25mg - gonadotropin-releasing hormone antagonists

Kanada - enska - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 3mg - cetrorelix (cetrorelix acetate) 3mg - gonadotropin-releasing hormone antagonists

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck serono ltd - cetrorelix acetate - powder and solvent for solution for injection - 3mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - ganirelix - solution for injection - 500microgram/1ml

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

laboratoires serono, switzerland - cetrorelix - powder, for solution - 0.25 mg

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

laboratoires serono - cetrorelix - powder and solvent for solution for injection - 0.25 mg

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

laboratoires serono, switzerland - cetrorelix - powder for solution for injection - 3 mg